GSK shares rise over 5% after Q4 results - MSN

GSK posted Q4 revenue of £8.12 billion, falling behind the consensus forecast of £9.86 billion. However, adjusted earnings per share came in at £0.23, below the £0.49 analysts were …


Install CouponFollow Chrome Extension   CouponFollow Extension

5%
OFF

GSK Shares Rise Over 5% After Q4 Results - MSN

2 weeks from now

GSK posted Q4 revenue of £8.12 billion, falling behind the consensus forecast of £9.86 billion. However, adjusted earnings per share came in at £0.23, below the £0.49 analysts were …

msn.com

5%
OFF

GSK Shares Leap 5% As Results Top Forecasts And Guidance Is ... - MSN

2 weeks from now

GSK shares ended 2024 on a sour note after what proved to be a rollercoaster year. The pharma giant dropped 7% over the 12 months, as worries over Zantac litigation and potential shake …

msn.com

6%
OFF

The GSK Share Price Jumps 6% On Positive FY 2024 Results. Is It A

2 weeks from now

The firm announced a Q4 dividend of 16p, bringing the full-year dividend up to 61p. To top it off, a £2bn share buyback programme was announced, to be carried out over the next 18 months.. …

msn.com

3%
OFF

GSK Surges After Bumping Its 2031 Outlook To North Of $50 Billion

2 weeks from now

2 days ago  · For the year, GSK guided to 3% to 5% sales growth. The company also projects core earnings growth of 6% to 8%. Analysts forecast earnings of $4.54 a share and $42.64 billion in …

investors.com

5%
OFF

GSK Shares Rise Over 5% After Q4 Results - Investing.com UK

2 weeks from now

3 days ago  · LONDON - On Wednesday, GlaxoSmithKline plc (NYSE: NYSE: GSK) shares gained 5.65% after the pharmaceutical giant reported fourth quarter revenue that beat analyst …

investing.com

5%
OFF

GSK Shares Rise Over 5% After Q4 Results - Investing.com India

2 weeks from now

3 days ago  · GSK shares rise over 5% after Q4 results . LONDON - On Wednesday, GlaxoSmithKline plc (NYSE: NYSE: GSK) shares gained 5.65% after the pharmaceutical giant …

investing.com

$0.59
OFF

GSK (GSK) Tops Q4 Earnings And Revenue Estimates - February 5, …

2 weeks from now

3 days ago  · GSK (GSK Quick Quote GSK - Free Report) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to …

zacks.com

5%
OFF

GSK Shares Rise Over 5% After Q4 Results - Investing.com Canada

2 weeks from now

3 days ago  · LONDON - On Wednesday, GlaxoSmithKline plc (NYSE: NYSE: GSK) shares gained 5.65% after the pharmaceutical giant reported fourth quarter revenue that beat analyst …

investing.com

6%
OFF

GSK Launches $2.5 Billion Buyback, Lifts Sales Target After ... - MSN

2 weeks from now

GSK's shares were up 6% at 1342 GMT after the British drugmaker's fourth-quarter results also topped expectations. Since taking the helm in 2017, CEO Emma Walmsley has returned GSK …

msn.com

£172
OFF

Full-year And Fourth Quarter 2024 - GSK

2 weeks from now

movements recorded for Haleon shares (Q4 2023: £172 million loss) following the sale of the remaining shares in May 2024. Other net income was higher compared to the same period last …

gsk.com

5%
OFF

GSK Shares Rise Over 5% After Q4 Results By Investing.com

2 weeks from now

3 days ago  · GSK posted Q4 revenue of £8.12 billion, falling behind the consensus forecast of £9.86 billion. However, adjusted earnings per share came in at £0.23, below the £0.49 …

investing.com

$2
OFF

GSK Stock Jumps On Long-Term Outlook Boost, $2.5B Share …

2 weeks from now

GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of …

msn.com

5%
OFF

GSK Shares Rise Over 5% After Q4 Results By Investing.com

2 weeks from now

3 days ago  · LONDON - On Wednesday, GlaxoSmithKline (LON: GSK) plc (NYSE: NYSE: GSK) shares gained 5.65% after the pharmaceutical giant reported fourth quarter revenue that beat …

investing.com

10%
OFF

GSK Boosts 2031 Revenue Target To Over £40bn Following Robust …

2 weeks from now

GSK boosts 2031 revenue target to over £40bn following robust Q4 results. ... per share of 159.3p, marking a 10% rise at constant exchange rates. ... of 16p per share for the fourth …

msn.com

5%
OFF

GSK Shares Rise Over 5% After Q4 Results - Investing.com

2 weeks from now

3 days ago  · GSK posted Q4 revenue of £8.12 billion, falling behind the consensus forecast of £9.86 billion. However, adjusted earnings per share came in at £0.23, below the £0.49 …

investing.com

FAQs about GSK shares rise over 5% after Q4 results - MSN Coupon?

Will GSK buy back 2 billion pounds of shares in 2025?

Stock Buyback: GSK also said it would buy back 2 billion pounds of shares over the next 18 months. Guidance: GSK expects 2025 sales to grow between 3% and 5%, with core earnings per share growing between 6% and 8%, including the benefit from the share buyback. ...

Will GSK increase its sales?

By Yadarisa Shabong (Reuters) -GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make up for pressures on its vaccines revenue. ...

Why did the GSK share price rise 6% This Morning?

The GSK share price rallied 6% this morning after the company published a surprisingly strong set of full-year results for 2024. Many metrics beat analysts’ expectations, including sales and revenue. The multinational pharmaceutical and biotechnology company had a tough year, with an extended drop in vaccine sales. ...

Did GlaxoSmithKline's Q4 earnings beat analyst estimates?

LONDON - On Wednesday, GlaxoSmithKline plc (NYSE: NYSE:GSK) shares gained 5.65% after the pharmaceutical giant reported fourth quarter revenue that beat analyst estimates, despite earnings falling short of expectations. GSK posted Q4 revenue of £8.12 billion, falling behind the consensus forecast of £9.86 billion. ...

Why did GSK (GSK) stock surge Wednesday?

GSK Plc's (GSK) U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a stock buyback on the back of optimism about sales of its new drugs. The British drug maker also reported higher-than-estimated fourth quarter results and sales growth next year. ...

What will GSK expect in 2025?

GSK also announced plans for a share buyback program over the next 18 months of 2 billion pounds ($2.5 billion). The company said it expects 2025 revenue to grow between 3% and 5%, even with vaccine sales likely to fall by a low-single-digit percentage. Analysts surveyed by Visible Alpha were looking for a revenue gain of around 4%. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension